Next Generation Antidepressants: Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders. Edited by Chad E. Beyer & Stephen M. Stahl. Cambridge University Press. 2010. £50 (hb). 150pp. ISBN: 9780521760584

Autor: Daniel J. Smith
Rok vydání: 2011
Předmět:
Zdroj: British Journal of Psychiatry. 198:499-499
ISSN: 1472-1465
0007-1250
DOI: 10.1192/bjp.bp.110.084376
Popis: [⇓][1] ![Figure][2] In 2010, three major pharmaceutical companies (GlaxoSmithKline, AstraZeneca and MSD) announced that they would be stopping their UK-based research into new treatments for psychiatric and neurological disease. This is likely to have profound repercussions, not only for
Databáze: OpenAIRE